• Nenhum resultado encontrado

Highly Active Antiretroviral Therapy (HAART)

Enteric Parasitic Infections in HIVAIDS Patients Before and After the Highly Active Antiretroviral Therapy

Enteric Parasitic Infections in HIVAIDS Patients Before and After the Highly Active Antiretroviral Therapy

... Enteroparasites are related to gastrointestinal alterations among patients with HIV/AIDS, some causing severe manifestations in the period before the institution of the highly active antiretroviral ...

8

Analysis of HIV- type 1 protease and reverse transcriptase in Brazilian children failing highly active antiretroviral therapy (HAART)

Analysis of HIV- type 1 protease and reverse transcriptase in Brazilian children failing highly active antiretroviral therapy (HAART)

... The aim of this study was to evaluate the genotypic resistance profiles of HIV-1 in children failing highly active antiretroviral therapy (HAART). Forty-one children (median age = 67 months) ...

5

Bezafibrate for the treatment of hypertriglyceridemia in HIV1-infected patients on highly active antiretroviral therapy

Bezafibrate for the treatment of hypertriglyceridemia in HIV1-infected patients on highly active antiretroviral therapy

... of highly active antiretroviral therapy (HAART) in HIV-infected patients has been associated with the development of risk factors for cardiovascular diseases (CD) including dyslipidemia and ...

6

The impact of highly active antiretroviral therapy on the survival of vertically hIV-infected children and adolescents in Belo horizonte, Brazil

The impact of highly active antiretroviral therapy on the survival of vertically hIV-infected children and adolescents in Belo horizonte, Brazil

... of highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV)-infected pa- tients has reduced the number of acquired immune deficiency syndrome-related deaths ...

7

Effectiveness of highly active antiretroviral therapy using non-brand name drugs in Brazil

Effectiveness of highly active antiretroviral therapy using non-brand name drugs in Brazil

... In Brazil, HIV-infected individuals receive drugs (including non- brand name drugs which comprise locally produced generics and drugs that have not been tested in bioequivalence trials) free of charge from the ...

5

Prevalence of Hypertension in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) Compared with HAART-Naive Patients at the Limbe Regional Hospital, Cameroon.

Prevalence of Hypertension in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) Compared with HAART-Naive Patients at the Limbe Regional Hospital, Cameroon.

... of highly active antiretroviral therapy (HAART) greatly reduced the morbid- ity and mortality due to HIV/AIDS, with patients experiencing longer and healthier lives ...of antiretroviral ...

11

Dyslipidemia in AIDS patients on highly active antiretroviral therapy

Dyslipidemia in AIDS patients on highly active antiretroviral therapy

... Highly active antiretroviral therapy (HAART) reduces AIDS-related morbidity and mortality, how- ever it has been associated with metabolic ...

5

Metabolic Effects Associated to the Highly Active Antiretroviral Therapy (HAART) in AIDS Patients

Metabolic Effects Associated to the Highly Active Antiretroviral Therapy (HAART) in AIDS Patients

... Highly active antiretroviral therapy (HAART) has dramatically improved the life expectancy of patients with human immunodeficiency virus ...different antiretroviral regimens with ...

7

Clinical features and outcomes of AIDS-related cytomegalovirus retinitis in the era of highly active antiretroviral therapy

Clinical features and outcomes of AIDS-related cytomegalovirus retinitis in the era of highly active antiretroviral therapy

... Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy. AIDS. 2000;14(9):1163-70. 8. Jabs DA, Van Natta ML, Thorne JE, ...

6

Neurobehavioral effects in HIV-positive individuals receiving highly active antiretroviral therapy (HAART) in Gaborone, Botswana.

Neurobehavioral effects in HIV-positive individuals receiving highly active antiretroviral therapy (HAART) in Gaborone, Botswana.

... All HIV+ subjects were on HAART and drug regimens were recorded for 95% of subjects. Seventy-eight percent of patients were on standard first line regimens consisting of two nucleoside (or nucleotide) analog reverse ...

7

Recurring Candida albicans Esophagitis in a HIV-Infected Patient Undergoing Long-Term Antiretroviral Therapy, and with Absent-Negligible Immunodeficiency

Recurring Candida albicans Esophagitis in a HIV-Infected Patient Undergoing Long-Term Antiretroviral Therapy, and with Absent-Negligible Immunodeficiency

... of highly active antiretroviral therapy (HAART) a dramatic drop of immunodeficiency-related opportunism occurred (especially for disorders associated with a CD4+ lymphocyte count below 50-100 ...

5

The Influence of HCV Coinfection on Clinical, Immunological and Virological Responses to HAART in HIV-Patients

The Influence of HCV Coinfection on Clinical, Immunological and Virological Responses to HAART in HIV-Patients

... Before the introduction of highly active antiretroviral therapy (HAART), HCV infection was not a relevant problem for the HIV-1 infected patients. However, as their life expectancy has ...

7

ASYMPTOMATIC ORAL CARRIAGE OF Candida SPECIES IN HIV-INFECTED PATIENTS IN THE HIGHLY ACTIVE ANTIRETROVIRAL THERAPY ERA

ASYMPTOMATIC ORAL CARRIAGE OF Candida SPECIES IN HIV-INFECTED PATIENTS IN THE HIGHLY ACTIVE ANTIRETROVIRAL THERAPY ERA

... correlation between the status of Candida carrier and the antiretroviral therapy. This could be explained by characteristics of isolates studied. All the isolates were considered commensal yeasts and not ...

5

Seguimento dos doentes soropositivos e soronegativos para o HIV com carcinoma espinocelular do canal anal.

Seguimento dos doentes soropositivos e soronegativos para o HIV com carcinoma espinocelular do canal anal.

... 5. Wexler A, Berson AM, Goldstone SE, Waltzman R, Penzer J, Maisonet OG et al. Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral ...

4

Sao Paulo Med. J.  vol.125 número5

Sao Paulo Med. J. vol.125 número5

... CASE REPORT A 54-year-old homosexual male pre- sented to us with a six-year history of recurrent anal warts. He had previously undergone incomplete surgical excision and fulguration of anal and perianal warts in another ...

3

Cad. Saúde Pública  vol.23 suppl.3

Cad. Saúde Pública vol.23 suppl.3

... Highly active antiretroviral therapy (HAART) has led to a substantial increase in the survival of people living with AIDS, despite heterogeneities among individuals from different ...

11

Immune recovery vitritis

Immune recovery vitritis

... a highly active antiretroviral therapy ...this therapy, there is an immune reconstitution in the body and inflammation of the vitreous ...

3

EFAVIRENZ-INDUCED GYNAECOMASTIA IN HIV INFECTED MALES: A REPORT OF 2 CASES

EFAVIRENZ-INDUCED GYNAECOMASTIA IN HIV INFECTED MALES: A REPORT OF 2 CASES

... INTRODUCTION: Highly active antiretroviral therapy (HAART) has revolutionised the treatment of HIV infected individuals, with reductions in morbidity and ...

4

Cardiovascular disease associated with human immunodeficiency virus : a review

Cardiovascular disease associated with human immunodeficiency virus : a review

... of highly active antiretroviral therapy (HAART) ...of antiretroviral treatment on their regression, as well as the metabolic and cardiovascular implications of HAART regimens in ...

13

The evolving landscape of the economics of HIV treatment and prevention.

The evolving landscape of the economics of HIV treatment and prevention.

... of highly active antiretroviral therapy (HAART) is not just a life-saving strategy for those infected with HIV, but it is also a highly effective means of preventing HIV ...

2

Show all 6205 documents...

temas relacionados